Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03302026 · ClinicalTrials.gov registry record · NA
Real Time fMRI and Quitting Smoking
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT03302026: Completed NA study, sponsored by University of Pennsylvania.
NCT03302026 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03302026, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study will examine how real-time functional magnetic resonance imaging (rt-fMRI) feedback can be used to modulate brain activation in the context of smoking cues in order to resist craving. Participants will complete a total of three fMRI scanning sessions with a cue suppression task with or without neurofeedback training (NFT). Participants will be randomized to an active group (active NFT) or a control group (no NFT) during the scanning sessions. At the end of the third session, all participants will complete a validated smoking lapse laboratory paradigm to evaluate effects of NFT on smoking behavior.
Interventions
- BEHAVIORAL Realtime biofeedback using fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2019-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03302026
The ClinicalTrials.gov registry entry for NCT03302026 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Realtime biofeedback using fMRI is the first listed.
NCT03302026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03302026 about?
NCT03302026 is a clinical study titled "Real Time fMRI and Quitting Smoking". This study will examine how real-time functional magnetic resonance imaging (rt-fMRI) feedback can be used to modulate brain activation in the context of smoking cues in order to resist craving. Participants will complete a total of three fMRI scanning sessions with a cue suppression task with or wi...
What is the current status of trial NCT03302026?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-01-02. Estimated completion is 2019-03-28.
What interventions are being tested in trial NCT03302026?
The interventions under investigation include: Realtime biofeedback using fMRI (BEHAVIORAL).
Who is sponsoring clinical trial NCT03302026?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.